#United States #Telehealth #Miami Beach #Chronic Pain #Adhere+

Adhere+ Achieves Recognition at the Business of Pain Conference

In a remarkable feat for the telehealth industry, Adhere+ has been awarded the prestigious Top Abstract honor at the 2025 Business of Pain meeting, set in Miami Beach, Florida. This recognition highlights the significant impact of their research on chronic pain management, demonstrating how remote therapeutic monitoring can lead to substantial improvements in patient care.

The Study Background

The abstract titled "Improving Engagement and Outcomes in Chronic Pain Management: Multi-Specialty Real-World Evidence from a Remote Therapeutic Monitoring Platform" was officially announced by Adhere+, a company known for its innovative SaaS-based platform that focuses on medication compliance and patient adherence. The abstract encompasses a comprehensive analysis of a staggering 2.7 million electronic patient-reported outcomes (ePROs) collected from 844,000 unique patients across 40 outpatient clinics nationwide. This research spanned various medical specialties, including pain management, behavioral health, orthopedics, and more.

Key Findings

Utilizing the Adhere+ platform, the study revealed impressive data reflecting a 30.4% decrease in anxiety, a 17.1% reduction in depression, a 17.2% drop in fatigue, and a 6.1% alleviation of pain over an 18-week period. One of the most compelling aspects of the research was the finding that provider alerts were generated in over 35% of monitored cases, allowing for timely interventions that could have been overlooked during typical visit schedules.

Dan Cohen, President and Co-Founder of Adhere+, stated, "These results showcase the power of remote therapeutic monitoring in enhancing patient engagement and bettering health outcomes while providing real-time support to healthcare providers."

Impact on Chronic Pain Care

Chronic pain is a leading concern, affecting more than 50 million Americans, while simultaneously escalating the risks associated with opioid use. Adhere+ aims to tackle these challenges by implementing a scalable telehealth solution designed to improve early intervention strategies and lessen the burden on healthcare providers. Through customizable daily check-ins, the platform collects ePROs that equip providers with real-time patient insights, ultimately fostering a more proactive healthcare environment.

As chronic pain continues to persist as a pivotal challenge in medical care, the implications of Adhere+’s research cannot be overstated. Leading pain management expert, Dr. Lynn Webster, who co-authored the study, noted, "This kind of real-world evidence paves the way for a more proactive and patient-centered approach to pain management, emphasizing the necessity for safety, efficacy, and efficiency in treatment protocols."

Event Highlights

The 2025 Business of Pain meeting spans a few days, from October 23 to October 26, and is renowned for exploring the convergence of pain medicine, science, and business practices. This award ceremony not only celebrates the dedication of professionals in the field but serves as a critical opportunity for stakeholders to converge and dialogue about advancements in pain management. Adhere+ will present its research on October 25 and accept the Top Abstract award, reflecting the ongoing commitment to enriching and transforming chronic pain care practices.

In conclusion, Adhere+ stands at the forefront of innovation in telehealth solutions, significantly influencing the landscape of chronic pain management. As they continue to lead the charge in enhancing patient compliance, their work is paving new paths towards safer, more responsive, and effective healthcare models for all individuals suffering from chronic pain.